Novel Gene Editing Platform Improves Safety and Precision in Stem Cells

Scientists have introduced a new gene editing platform, named SMArT, which significantly boosts the targeted integration of gene-sized cassettes into hematopoietic stem and progenitor cells. This system allows for the purification of edited cells to nearly 100% while also eliminating cells with unintended and potentially harmful genetic changes. This development addresses a crucial safety concern in the field of gene therapy.